DK358384A - Farmaceutiske midler til bekaempelse af diabetes mellitus - Google Patents

Farmaceutiske midler til bekaempelse af diabetes mellitus Download PDF

Info

Publication number: DK358384A
Authority: DK; Denmark
Prior art keywords: diabetes mellitus; denotes; pharmaceutical agents; phe; formula
Prior art date: 1983-07-22

Application number

DK358384A

Other languages

English (en)

Other versions

DK358384D0 (da

DK172456B1 (da

Inventor

Ulrich Grau

Original Assignee

Hoechst Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1983-07-22

Filing date

1984-07-20

Publication date

1985-01-23

1984-07-20 Application filed by Hoechst Ag filed Critical Hoechst Ag

1984-07-20 Publication of DK358384D0 publication Critical patent/DK358384D0/da

1985-01-23 Publication of DK358384A publication Critical patent/DK358384A/da

1998-08-24 Application granted granted Critical

1998-08-24 Publication of DK172456B1 publication Critical patent/DK172456B1/da

Links

206010012601 diabetes mellitus Diseases 0.000 title abstract 2
239000008177 pharmaceutical agent Substances 0.000 title 1
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical class N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 3
102000004877 Insulin Human genes 0.000 abstract 1
108090001061 Insulin Proteins 0.000 abstract 1
125000004432 carbon atom Chemical group C* 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
229940125396 insulin Drugs 0.000 abstract 1
239000004026 insulin derivative Substances 0.000 abstract 1
230000007935 neutral effect Effects 0.000 abstract 1
125000000962 organic group Chemical group 0.000 abstract 1
239000000546 pharmaceutical excipient Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
- C07K14/625—Extraction from natural sources
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Gastroenterology & Hepatology (AREA)
Toxicology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Endocrinology (AREA)
Zoology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Diabetes (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Prostheses (AREA)
Steroid Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK198403583A 1983-07-22 1984-07-20 Lægemidler indeholdende insulinderivater til behandling af diabetes mellitus DK172456B1 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE3326473		1983-07-22
DE19833326473 DE3326473A1 (de)	1983-07-22	1983-07-22	Pharmazeutisches mittel zur behandlung des diabetes mellitus

Publications (3)

Publication Number	Publication Date
DK358384D0 DK358384D0 (da)	1984-07-20
DK358384A true DK358384A (da)	1985-01-23
DK172456B1 DK172456B1 (da)	1998-08-24

Family

ID=6204661

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK198403583A DK172456B1 (da)	1983-07-22	1984-07-20	Lægemidler indeholdende insulinderivater til behandling af diabetes mellitus

Country Status (19)

Country	Link
US (1)	US4608364A (da)
EP (1)	EP0132769B1 (da)
JP (1)	JPS6042334A (da)
AT (1)	ATE31625T1 (da)
AU (1)	AU564648B2 (da)
CA (1)	CA1236012A (da)
DE (2)	DE3326473A1 (da)
DK (1)	DK172456B1 (da)
ES (1)	ES534488A0 (da)
FI (1)	FI79786C (da)
GR (1)	GR81550B (da)
HU (1)	HUT34889A (da)
IE (1)	IE57690B1 (da)
IL (1)	IL72468A (da)
NO (1)	NO167187C (da)
NZ (1)	NZ208960A (da)
PH (1)	PH21328A (da)
PT (1)	PT78941A (da)
ZA (1)	ZA845621B (da)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5008241A (en) *	1985-03-12	1991-04-16	Novo Nordisk A/S	Novel insulin peptides
US4946828A (en) *	1985-03-12	1990-08-07	Novo Nordisk A/S	Novel insulin peptides
WO1988006599A1 (en) *	1987-02-25	1988-09-07	Novo Industri A/S	Novel insulin derivatives
US4764592A (en) *	1987-04-23	1988-08-16	Eli Lilly And Company	Crystalline human proinsulin and process for its production
DE3717370A1 (de) *	1987-05-22	1988-12-01	Hoechst Ag	Mischkristalle aus insulin und insulinderivaten, verfahren zur herstellung dieser mischkristalle, diese mischkristalle enthaltende pharmazeutische mittel und ihre verwendung zur behandlung von diabetes mellitus
US4789660A (en) *	1987-09-10	1988-12-06	American Home Products Corporation	Insulin administration using methyl and propyl paraben
US6875589B1 (en)	1988-06-23	2005-04-05	Hoechst Aktiengesellschaft	Mini-proinsulin, its preparation and use
ATE101620T1 (de) *	1988-06-23	1994-03-15	Hoechst Ag	Mini-proinsulin, seine herstellung und verwendung.
DE3827533A1 (de) *	1988-08-13	1990-02-15	Hoechst Ag	Pharmazeutische zubereitung zur behandlung des diabetes mellitus
DE3837825A1 (de) *	1988-11-08	1990-05-10	Hoechst Ag	Neue insulinderivate, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
DK134189D0 (da) *	1989-03-20	1989-03-20	Nordisk Gentofte	Insulinforbindelser
DE3936876A1 (de) *	1989-11-06	1991-05-23	Hoechst Ag	Neue insulinderivate, verfahren zu deren herstellung, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
IL99699A (en) *	1990-10-10	2002-04-21	Autoimmune Inc	Drug with the option of oral, intra-intestinal, or inhaled dosing for suppression of autoimmune response associated with type I diabetes
AU9172991A (en)	1990-12-07	1992-07-08	Cnc Development, Inc.	Catalytic chemical reactor
YU66892A (sh) *	1991-08-20	1995-10-24	Hoechst Ag.	Fosfoinositolglikan - peptid sa delovanjem kao insulin
NZ245170A (en) *	1991-11-26	1994-07-26	Lilly Co Eli	Insulin and proinsulin analogues with arg at b31, b32 and ao and pharmaceutical compositions
DE59209745D1 (de) *	1991-11-29	1999-10-21	Hoechst Ag	Peptide mit insulinartiger Wirkung
CA2087087C (en) *	1992-01-22	2000-07-18	Burton H. Sage, Jr.	Molecules for iontophoretic delivery
DK72793D0 (da) *	1993-06-21	1993-06-21	Novo Nordisk As	Nyt produkt
US5461031A (en) *	1994-06-16	1995-10-24	Eli Lilly And Company	Monomeric insulin analog formulations
US5547929A (en) *	1994-09-12	1996-08-20	Eli Lilly And Company	Insulin analog formulations
US6451970B1 (en)	1996-02-21	2002-09-17	Novo Nordisk A/S	Peptide derivatives
SE520392C2 (sv)	1996-09-27	2003-07-01	Creative Peptides Sweden Ab C	Specifika peptider för behandling av diabetes mellitus
DE19649350A1 (de) *	1996-11-28	1998-06-04	Hoechst Ag	Inositolglykane mit insulinartiger Wirkung
US6444641B1 (en)	1997-10-24	2002-09-03	Eli Lilly Company	Fatty acid-acylated insulin analogs
SV1998000125A (es)	1997-10-24	1999-05-24	Lilly Co Eli	Composiciones de insulina insoluble ref. x-11232
US6531448B1 (en)	1997-12-23	2003-03-11	Eli Lilly And Company	Insoluble compositions for controlling blood glucose
AU763039B2 (en) *	1999-04-08	2003-07-10	Genentech Inc.	Composition based on oppositely-charged polypeptides
WO2002067969A2 (en)	2001-02-21	2002-09-06	Medtronic Minimed, Inc.	Stabilized insulin formulations
DE10114178A1 (de)	2001-03-23	2002-10-10	Aventis Pharma Gmbh	Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
DE10227232A1 (de) *	2002-06-18	2004-01-15	Aventis Pharma Deutschland Gmbh	Saure Insulinzubereitungen mit verbesserter Stabilität
GB0323979D0 (en)	2003-10-13	2003-11-19	Creative Peptides Sweden Ab	Therapeutic applications for c-peptide
GB0601950D0 (en) *	2006-01-31	2006-03-15	Creative Peptides Sweden Ab	Compositions and methods of treating diabetes
DE102006031955A1 (de)	2006-07-11	2008-01-17	Sanofi-Aventis Deutschland Gmbh	Verfahren zur Herstellung von Insulinanaloga mit dibasischem B-Kettenende
DE102006031962A1 (de)	2006-07-11	2008-01-17	Sanofi-Aventis Deutschland Gmbh	Amidiertes Insulin Glargin
AU2009292643B2 (en)	2008-09-19	2016-02-18	Nektar Therapeutics	Polymer conjugates of therapeutic peptides
EP3228320B1 (de)	2008-10-17	2019-12-18	Sanofi-Aventis Deutschland GmbH	Kombination von einem insulin und einem glp-1-agonisten
EP3202394A1 (de)	2009-07-06	2017-08-09	Sanofi-Aventis Deutschland GmbH	Wässrige insulinzubereitungen enthaltend methionin
US8410049B2 (en) *	2009-10-28	2013-04-02	Cebix	Methods and kits for preventing hypoglycemia
PT2554183T (pt)	2009-11-13	2018-07-09	Sanofi Aventis Deutschland	Composição farmacêutica que compreende um agonista de glp-1, uma insulina e metionina
PE20121316A1 (es)	2009-11-13	2012-10-05	Sanofi Aventis Deutschland	Composicion farmaceutica que comprende un agonista de glp-1 y metionina
US20140148384A1 (en)	2010-08-30	2014-05-29	Sanofi-Aventis Deutschland Gmbh	Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2
US9821032B2 (en)	2011-05-13	2017-11-21	Sanofi-Aventis Deutschland Gmbh	Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
CN108079281A (zh)	2011-08-29	2018-05-29	赛诺菲-安万特德国有限公司	用于2型糖尿病患者中的血糖控制的药物组合
TWI559929B (en)	2011-09-01	2016-12-01	Sanofi Aventis Deutschland	Pharmaceutical composition for use in the treatment of a neurodegenerative disease
TWI758239B (zh)	2014-12-12	2022-03-21	德商賽諾菲阿凡提斯德意志有限公司	甘精胰島素/利司那肽固定比率配製劑
TWI748945B (zh)	2015-03-13	2021-12-11	德商賽諾菲阿凡提斯德意志有限公司	第２型糖尿病病患治療
TW201705975A (zh)	2015-03-18	2017-02-16	賽諾菲阿凡提斯德意志有限公司	第２型糖尿病病患之治療
WO2017205309A1 (en) *	2016-05-25	2017-11-30	Merck Sharp & Dohme Corp.	Insulin receptor partial agonists
WO2025068976A1 (en)	2023-09-28	2025-04-03	Biotts Inc.	Compositions comprising insulin agonists, and said compositions for use in the treatment of diabetes or obesity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZW17682A1 (en) *	1981-08-27	1982-11-24	Lilly Co Eli	Pharmaceutical formulations comprising human insulin human c-peptide and human proinsulin
DOP1982004086A (es) *	1981-08-27	1988-03-22	Lilly Co Eli	Formula farmaceutica que comprende insulina humana y proinsulina humana
CA1176158A (en) *	1981-08-27	1984-10-16	Ronald E. Chance	Pharmaceutical formulations comprising human insulin and human c-peptide
CH650677A5 (de) *	1981-08-27	1985-08-15	Lilly Co Eli	Gegen diabetes mellitus wirksames pharmazeutisches mittel.
NL8201650A (nl) *	1982-04-21	1983-11-16	Akzo Nv	Semisynthetische bereiding van humane insuline.

1983
- 1983-07-22 DE DE19833326473 patent/DE3326473A1/de not_active Withdrawn
1984
- 1984-07-16 HU HU842765A patent/HUT34889A/hu unknown
- 1984-07-18 DE DE8484108441T patent/DE3468323D1/de not_active Expired
- 1984-07-18 GR GR75341A patent/GR81550B/el unknown
- 1984-07-18 AT AT84108441T patent/ATE31625T1/de not_active IP Right Cessation
- 1984-07-18 EP EP84108441A patent/EP0132769B1/de not_active Expired
- 1984-07-19 PT PT78941A patent/PT78941A/pt not_active IP Right Cessation
- 1984-07-19 FI FI842915A patent/FI79786C/fi not_active IP Right Cessation
- 1984-07-20 NZ NZ208960A patent/NZ208960A/xx unknown
- 1984-07-20 ES ES534488A patent/ES534488A0/es active Granted
- 1984-07-20 AU AU30917/84A patent/AU564648B2/en not_active Ceased
- 1984-07-20 IL IL72468A patent/IL72468A/xx not_active IP Right Cessation
- 1984-07-20 US US06/632,859 patent/US4608364A/en not_active Expired - Lifetime
- 1984-07-20 ZA ZA845621A patent/ZA845621B/xx unknown
- 1984-07-20 JP JP59149785A patent/JPS6042334A/ja active Granted
- 1984-07-20 NO NO842978A patent/NO167187C/no unknown
- 1984-07-20 PH PH31011A patent/PH21328A/en unknown
- 1984-07-20 CA CA000459385A patent/CA1236012A/en not_active Expired
- 1984-07-20 IE IE1890/84A patent/IE57690B1/en not_active IP Right Cessation
- 1984-07-20 DK DK198403583A patent/DK172456B1/da not_active IP Right Cessation

Also Published As

Publication number	Publication date
HUT34889A (en)	1985-05-28
ZA845621B (en)	1985-02-27
FI842915L (fi)	1985-01-23
IE841890L (en)	1985-01-22
ES8504456A1 (es)	1985-05-01
DK358384D0 (da)	1984-07-20
AU3091784A (en)	1985-01-24
DE3326473A1 (de)	1985-01-31
AU564648B2 (en)	1987-08-20
FI79786B (fi)	1989-11-30
US4608364A (en)	1986-08-26
ES534488A0 (es)	1985-05-01
PH21328A (en)	1987-10-13
DE3468323D1 (en)	1988-02-11
PT78941A (de)	1984-08-01
CA1236012A (en)	1988-05-03
ATE31625T1 (de)	1988-01-15
JPH0469128B2 (da)	1992-11-05
NO842978L (no)	1985-01-23
GR81550B (da)	1984-12-11
NO167187C (no)	1991-10-16
NZ208960A (en)	1989-02-24
EP0132769A1 (de)	1985-02-13
IL72468A (en)	1989-08-15
NO167187B (no)	1991-07-08
IE57690B1 (en)	1993-03-10
DK172456B1 (da)	1998-08-24
FI842915A0 (fi)	1984-07-19
FI79786C (fi)	1990-03-12
JPS6042334A (ja)	1985-03-06
EP0132769B1 (de)	1988-01-07
IL72468A0 (en)	1984-11-30

Legal Events

Date	Code	Title	Description
1998-08-24	B1	Patent granted (law 1993)
2003-03-03	PBP	Patent lapsed	Country of ref document: DK

Publication	Publication Date	Title
DK358384A (da)	1985-01-23	Farmaceutiske midler til bekaempelse af diabetes mellitus
ES8505646A1 (es)	1985-06-01	Procedimiento para la preparacion de un derivado de insulina
GR1001503B (el)	1994-02-28	Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
SE8102194L (sv)	1982-10-07	Terapeutiskt aktiv organisk forening och farmaceutisk beredning innehallande denna
FI98460B (fi)	1997-03-14	Menetelmä terapeuttisesti käyttökelpoisen 4H-1-bentsopyran-4-onijohdoksen tai sen suolan valmistamiseksi ja menetelmässä käyttökelpoinen välituote
DE69025336D1 (de)	1996-03-21	Antihypertensive Zubereitungen und deren Verwendung
SE8102193L (sv)	1982-10-07	Terapeutiskt aktiv organisk forening och dess anvendning
DE69111205D1 (de)	1995-08-17	Stabilisierung von Calcitonin enthaltenden pharmazeutischen Verbindungen.
HUT38950A (en)	1986-07-28	Process for producing 2-substituted-1,3-propylidene-diphosphonate derivatives and pharmaceutical compositions containing them as active agents
DK296389D0 (da)	1989-06-15	Farmaceutiske forbindelser
SE8202380L (sv)	1982-10-17	Analgetisk komposition
DK204686A (da)	1986-11-07	Quinolylglycinamidderivater og fremgangsmaade til fremstilling deraf
HUT55034A (en)	1991-04-29	Process for producing peptides with hemoregulating effect and pharmaceutical compositions comprising such compounds as active ingredient
BG60101B2 (bg)	1993-10-29	Метод за получаване на 4-флуор-2-(((4-метокси-2- пиридинил)метил)тионил)-1н-бензимидазол
NO911119L (no)	1991-09-23	Fremgangsmaate for fremstilling av farmasoeytisk jodpreparat
JPS5344616A (en)	1978-04-21	Injections
ZA896617B (en)	1990-06-27	Sulphonamides,processes for their preparation and pharmaceutical compositions
GB2021581A (en)	1979-12-05	Stabilisation of PGl2 derivatives
KR940002268A (ko)	1994-02-17	21-클로로-프레그난 유도체
JPS5251362A (en)	1977-04-25	Preparation of optically active pyrrolidine derivatives
TH6020B (th)	1996-08-20	สูตรผสมเมนาไดโอนไบซัลโฟท์ที่ได้ทำให้เสถียร และการเตรียมสูตรผสมเหล่านี้